Equity Research Household & Personal Products

Should You Buy The Clorox Company Stock in 2026?

By CirclFi Research Team · · Updated · 11/13 models active

According to the CirclFi Deep Alpha Valuation Engine, The Clorox Company (CLX) is rated as a strong fundamental performer with a QOC score of 7.9/10. Trading at $87.16, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.

The short answer: 8 of 11 CirclFi valuation models project upside for The Clorox Company (CLX) at $87.16 — the model consensus leans bullish, with a Quality Score of 7.9/10 and Value-Trap risk of 6/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 8 of 11 models see upside — majority bullish
  • Quality Score: 7.9/10 — Strong — above-average quality
  • Value Trap Risk: 6/100 — Minimal — healthy fundamentals
  • Fair Value Range: $34.45 – $172.62 (401% spread)

Bullish Models

8 / 11

Bearish Models

3 / 11

Quality Score

7.9 /10

Strong — above-average quality

Value Trap Risk

6 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

11 /13
Active Models

Avg. confidence: 57%

What Is the Investment Case for The Clorox Company (CLX) in 2026?

What Is the Bull Case vs the Bear Case for The Clorox Company (CLX)?

Bull case versus bear case for The Clorox Company (CLX) at $87.16, derived from 11 active CirclFi valuation models on 2026-09-15.
Bull case — $172.62 target (+98.1%) Bear case — $34.45 target (-60.5%)
According to the CirclFi Quality of Company (QOC) framework, The Clorox Company's rating of 7.9/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably. According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $34.45 (-60.5%), suggesting that the market price embeds overly optimistic growth assumptions.
According to the CirclFi Deep Alpha Valuation Engine, 8 of 11 models identify upside from $87.16 to a median fair value of $114.89, indicating the market hasn't fully priced in The Clorox Company's earnings power. According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +158.5% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.
According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $172.62 (+98.1%), anchoring the bull case with a methodology that provides a differentiated analytical lens. Industry headwind: e-commerce disruption represents a meaningful risk for The Clorox Company and its Household & Personal Products peers.
Industry tailwind: geographic expansion could provide meaningful support for The Clorox Company's revenue and margin trajectory in the Household & Personal Products space.

How Does CLX Compare to Its Household & Personal Products Peers?

KMB Kimberly-Clark Corpo
8.0
SPB Spectrum Brands Hold
7.7
UG United-Guardian, Inc
8.1
NUS Nu Skin Enterprises,
7.7
ELF e.l.f. Beauty, Inc.
8.1
UL Unilever PLC
7.6
SLSN Solesence, Inc.
6.8
SKIN SkinHealth Systems I
6.0

Valuation data pages: KMB · SPB · UG · NUS · ELF · UL · SLSN · SKIN · TANH · IPAR · PG

Which Other Stocks Score Like CLX on Quality?

Closest companies to CLX’s Quality of Company score of 7.9/10, across all industries.

  • ENVA — Enova International, Inc. (QOC 7.9) · analysis
  • FAF — First American Financial Corporation (QOC 7.9) · analysis
  • AWR — American States Water Company (QOC 7.9) · analysis
  • MUFG — Mitsubishi UFJ Financial Group, Inc. (QOC 7.9) · analysis
  • CCK — Crown Holdings, Inc. (QOC 7.9) · analysis
  • LTH — Life Time Group Holdings, Inc. (QOC 7.9) · analysis
  • NVDA — NVIDIA Corporation (QOC 10.0) · analysis

Why Do CirclFi’s 11 Models Disagree on CLX?

Spread

401%

Fair Value Range

$34.45 – $172.62

A 401% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Regime Cross

$172.62 (+98.1%)

Most Bearish

EROIC

$34.45 (-60.5%)

What Are the Biggest Risks of Buying CLX Stock?

Model Disagreement

401% spread signals high variance in projections.

Macro/Sector Risk

Household & Personal Products headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View CLX Data Page →

So Is The Clorox Company (CLX) Worth Buying in 2026?

The balance of evidence tilts cautiously positive for The Clorox Company at $87.16. 8 of 11 models support upside to $114.89, backed by a 7.9/10 quality foundation. This is a "lean into, not load up on" setup in our framework.

These are quantitative model outputs, not investment recommendations. The Clorox Company's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About CLX Stock?

Should I buy CLX stock right now?

Based on CirclFi's multi-model analysis, 8 of 11 models see upside for CLX at $87.16. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.9/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in The Clorox Company?

Key risks include: wide model disagreement (401% spread), signaling high uncertainty; general market and sector-specific risks affecting Household & Personal Products companies. Always diversify and consult a financial advisor.

How does CLX compare to its competitors?

Among Household & Personal Products peers, CLX holds a Quality Score of 7.9/10. Comparable companies include KMB (QOC 8.0), SPB (QOC 7.7), UG (QOC 8.1). The relative ranking helps investors identify whether CLX offers better fundamental quality than alternatives in the same sector.

Is CLX a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CLX's Quality Score of 7.9/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy CLX at?

CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $34.45 to $172.62. At $87.16, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for CLX.

View CLX Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →